Wellgistics Health, Inc. Common Stock
Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, … Read more
Wellgistics Health, Inc. Common Stock (WGRX) - Net Assets
Latest net assets as of September 2025: $6.78 Million USD
Based on the latest financial reports, Wellgistics Health, Inc. Common Stock (WGRX) has net assets worth $6.78 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($52.78 Million) and total liabilities ($46.00 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.78 Million |
| % of Total Assets | 12.84% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Wellgistics Health, Inc. Common Stock - Net Assets Trend (2022–2024)
This chart illustrates how Wellgistics Health, Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Wellgistics Health, Inc. Common Stock (2022–2024)
The table below shows the annual net assets of Wellgistics Health, Inc. Common Stock from 2022 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $6.73 Million | +332.19% |
| 2023-12-31 | $-2.90 Million | -55146.36% |
| 2022-12-31 | $-5.25K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Wellgistics Health, Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 975191000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $5.11K | 0.08% |
| Other Components | $16.49 Million | 244.81% |
| Total Equity | $6.73 Million | 100.00% |
Wellgistics Health, Inc. Common Stock Competitors by Market Cap
The table below lists competitors of Wellgistics Health, Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Rohas Tecnic Bhd
KLSE:9741
|
$6.11 Million |
|
Dc Infotech And Communication Limited
NSE:DCI
|
$6.11 Million |
|
Auriginal Mining Corp.
V:AUME
|
$6.12 Million |
|
Airan Limited
NSE:AIRAN
|
$6.12 Million |
|
Kadimastem Ltd
PINK:KMSTF
|
$6.11 Million |
|
Mycodern S.A.
F:GY3
|
$6.11 Million |
|
HF COMPANY INH. EO -50
F:HFC
|
$6.10 Million |
|
Inter-Rock Minerals Inc
PINK:IRCKF
|
$6.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Wellgistics Health, Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -2,900,434 to 6,734,446, a change of 9,634,880.
- Net loss of 6,856,226 reduced equity.
- New share issuances of 10,000 increased equity.
- Other factors increased equity by 16,481,106.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-6.86 Million | -101.81% |
| Share Issuances | $10.00K | +0.15% |
| Other Changes | $16.48 Million | +244.73% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Wellgistics Health, Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.20x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | $0.00 | $0.16 | x |
| 2023-12-31 | $-0.06 | $0.16 | x |
| 2024-12-31 | $0.13 | $0.16 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Wellgistics Health, Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -101.81%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -37.82%
- • Asset Turnover: 0.32x
- • Equity Multiplier: 8.51x
- Recent ROE (-101.81%) is below the historical average (-33.94%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 0.00% | -8.37% | 0.00x | 0.00x | $-2.74 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.61 Million |
| 2024 | -101.81% | -37.82% | 0.32x | 8.51x | $-7.53 Million |
Industry Comparison
This section compares Wellgistics Health, Inc. Common Stock's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $239,198,060
- Average return on equity (ROE) among peers: -6.39%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Wellgistics Health, Inc. Common Stock (WGRX) | $6.78 Million | 0.00% | 6.79x | $6.11 Million |
| Alibaba Health Information Technology Limited (ALBBY) | $1.12 Billion | -18.54% | 0.50x | $12.50 Billion |
| Allstar Health Brands Inc (ALST) | $-9.92 Million | 0.00% | 0.00x | $3.83 |
| Bimi International Medical Inc (BIMI) | $-409.66K | 0.00% | 0.00x | $296.83 |
| Blum Holdings Inc (BLMH) | $-4.74 Million | 0.00% | 0.00x | $8.97 Million |
| China Jo-Jo Drugstores Inc (CJJD) | $26.66 Million | -21.17% | 1.52x | $5.94 Million |
| Clicks Group Ltd (CLCGY) | $1.13 Billion | 41.98% | 2.72x | $4.80 Billion |
| China BCT Pharmacy Group Inc (CNBI) | $134.27 Million | 15.68% | 0.82x | $0.96 |
| Dalrada Financial Corp (DFCO) | $4.40 Million | -81.82% | 0.55x | $1.57 Million |
| Health Advance Inc (HADV) | $-105.34K | 0.00% | 0.00x | $25.40K |
| Healthwarehouse.Com (HEWA) | $-3.10 Million | 0.00% | 0.00x | $720.96 |